BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24840789)

  • 1. Breaking bad - the two sides of gut microbiota in portal hypertension.
    Mehta G; Mookerjee RP
    Liver Int; 2014 Oct; 34(9):1295-7. PubMed ID: 24840789
    [No Abstract]   [Full Text] [Related]  

  • 2. Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg.
    Arab JP; Martin-Mateos RM; Shah VH
    Hepatol Int; 2018 Feb; 12(Suppl 1):24-33. PubMed ID: 28550391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota-related complications in cirrhosis.
    Gómez-Hurtado I; Such J; Sanz Y; Francés R
    World J Gastroenterol; 2014 Nov; 20(42):15624-31. PubMed ID: 25400446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploratory Research on the Relationship between Human Gut Microbiota and Portal Hypertension.
    Yokoyama K; Tsuchiya N; Yamauchi R; Miyayama T; Uchida Y; Shibata K; Fukuda H; Umeda K; Takata K; Tanaka T; Inomata S; Morihara D; Takeyama Y; Shakado S; Sakisaka S; Hirai F
    Intern Med; 2020; 59(17):2089-2094. PubMed ID: 32879200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probiotics in Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, and Cirrhosis.
    Qamar AA
    J Clin Gastroenterol; 2015; 49 Suppl 1():S28-32. PubMed ID: 26447961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Disorders of gut microflora in the pathogenesis of liver cirrhosis and complications of portal hypertension].
    Anikina EV; Kovtun AV; Iakovenko AV; Gioeva IZ; Iakovenko ÉP; Agafonova NA; Ivanov AN; Volosheĭnikova TV; Grigor'eva IuV
    Eksp Klin Gastroenterol; 2014; (12):20-3. PubMed ID: 26058107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal epithelial barrier function in liver cirrhosis: an extensive review of the literature.
    Pijls KE; Jonkers DM; Elamin EE; Masclee AA; Koek GH
    Liver Int; 2013 Nov; 33(10):1457-69. PubMed ID: 23879434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the gut-liver axis in cirrhosis: antibiotics and non-selective β-blockers.
    Madsen BS; Havelund T; Krag A
    Adv Ther; 2013 Jul; 30(7):659-70. PubMed ID: 23881723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiome and bacterial translocation in cirrhosis.
    Gómez-Hurtado I; Such J; Francés R
    Gastroenterol Hepatol; 2016 Dec; 39(10):687-696. PubMed ID: 26775042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Medical therapy of portal hypertension due to liver cirrhosis].
    Cerini R; Sperandeo M; Varriale A; De Rosa ML; Cacciatore L
    Recenti Prog Med; 1991 Feb; 82(2):91-9. PubMed ID: 2034876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of anaprilin for the correction of portal hypertension in liver cirrhosis].
    Bondarenko IP; Dubinskiĭ AA; Tereshkin IG
    Vrach Delo; 1989 Nov; (11):19-22. PubMed ID: 2609578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the adjunctive probiotic VSL#3 on portal haemodynamics in patients with cirrhosis and large varices: a randomized trial.
    Gupta N; Kumar A; Sharma P; Garg V; Sharma BC; Sarin SK
    Liver Int; 2013 Sep; 33(8):1148-57. PubMed ID: 23601333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vasodilator agents in portal hypertension].
    Combis JM; Vinel JP
    Gastroenterol Clin Biol; 1991; 15(12):881-7. PubMed ID: 1686004
    [No Abstract]   [Full Text] [Related]  

  • 14. [Aspects of pathogenetc pharmacotherapy for portal hypertension in liver cirrhosis].
    Garbuzenko DV
    Ter Arkh; 2016; 88(2):101-108. PubMed ID: 27135108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemodynamic disorders due to liver cirrhosis].
    Garbuzenko DV
    Klin Med (Mosk); 1996; 74(2):5-7. PubMed ID: 8772089
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacological modulation of portal hypertension syndrome: current status and future prospects].
    González García M; Albillos Martínez A
    Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():1-7. PubMed ID: 15195528
    [No Abstract]   [Full Text] [Related]  

  • 17. [Physiopathology of portal hypertension in liver cirrhosis].
    Cervela LA
    Rev Esp Enferm Apar Dig; 1973 Jan; 39(2):223-38. PubMed ID: 4690385
    [No Abstract]   [Full Text] [Related]  

  • 18. Does losartan work after all?
    Blendis LM; Wong F
    Am J Gastroenterol; 2003 Jun; 98(6):1222-4. PubMed ID: 12818261
    [No Abstract]   [Full Text] [Related]  

  • 19. [Physiopathologic basis of medical therapy of portal hypertension in cirrhosis].
    Gatta A; Bolognesi M; Sacerdoti D; Merkel C
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():39S-47S. PubMed ID: 9004819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Portal hypertension in the absence of liver cirrhosis and extrahepatic circulatory blockade].
    Bykov VS
    Klin Med (Mosk); 1981 Oct; 59(10):22-6. PubMed ID: 7031355
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.